|
1
|
Ye X, Fan C, Ku Z, Zuo T, Kong L, Zhang C,
Shi J, Liu Q, Chen T, Zhang Y, et al: Structural basis for
recognition of human enterovirus 71 by a bivalent broadly
neutralizing monoclonal antibody. PLoS Pathog. 12:e10054542016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gui J, Liu Z, Zhang T, Hua Q, Jiang Z,
Chen B, Gu H, Lv H and Dong C: Epidemiological characteristics and
spatial-temporal clusters of hand, foot and mouth disease in
zhejiang province, China, 2008–2012. PLoS One. 10:e01391092015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT,
Tsai SF, Wang JR and Shih SR: An epidemic of enterovirus 71
infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N
Engl J Med. 341:929–935. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu W, Liu CF, Yan L, Li JJ, Wang LJ, Qi Y,
Cheng RB and Xiong XY: Distribution of enteroviruses in
hospitalized children with hand, foot and mouth disease and
relationship between pathogens and nervous system complications.
Virol J. 9:82012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qin B, Zhang J, Xie W, Liu X, He T, Chen J
and Dong X: Development of a specific latex agglutination test to
detect antibodies of enterovirus 71. Arch Med Res. 46:580–587.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qing J, Wang Y, Sun Y, Huang J, Yan W,
Wang J, Su D, Ni C, Li J, Rao Z, et al: Cyclophilin A associates
with enterovirus-71 virus capsid and plays an essential role in
viral infection as an uncoating regulator. PLoS Pathog.
10:e10044222014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu CC, Chow YH, Chong P and Klein M:
Prospect and challenges for the development of multivalent vaccines
against hand, foot and mouth diseases. Vaccine. 32:6177–6182. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liang ZL, Mao QY, Wang YP, Zhu FC, Li JX,
Yao X, Gao F, Wu X, Xu M and Wang JZ: Progress on the research and
development of inactivated EV71 whole-virus vaccines. Hum Vaccin
Immunother. 9:1701–1705. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ren J, Wang X, Zhu L, Hu Z, Gao Q, Yang P,
Li X, Wang J, Shen X, Fry EE, et al: Structures of Coxsackievirus
A16 capsids with native antigenicity: Implications for particle
expansion, receptor binding and immunogenicity. J Virology.
89:10500–10511. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chang J, Li J, Wei W, Liu X, Liu G, Yang
J, Zhang W and Yu XF: Determinants of EV71 immunogenicity and
protection against lethal challenge in a mouse model. Immunol Res.
62:306–315. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ng Q, He F and Kwang J: Recent Progress
towards Novel EV71 anti-therapeutics and vaccines. Viruses.
7:6441–6457. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li X, Fan P, Jin J, Su W, An D, Xu L, Sun
S, Zhang Y, Meng X, Gao F, et al: Establishment of cell lines with
increased susceptibility to EV71/CA16 by stable overexpression of
SCARB2. Virol J. 10:2502013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang YF, Chou CT, Lei HY, Liu CC, Wang SM,
Yan JJ, Su IJ, Wang JR, Yeh TM, Chen SH and Yu CK: A mouse-adapted
enterovirus 71 strain causes neurological disease in mice after
oral infection. J Virol. 78:7916–7924. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shih SR, Li YS, Chiou CC, Suen PC, Lin TY,
Chang LY, Huang YC, Tsao KC, Ning HC, Wu TZ and Chan EC: Expression
of capsid [correction of caspid] protein VP1 for use as antigen for
the diagnosis of enterovirus 71 infection. J Med Virol. 61:228–234.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bo HT: tCJkZJhJZjHXnFLjQ: A study on
genetic characteristics of Enterovirus 71 of hand-foot-mouth
disease in Shaoxing city Zhejiang. Prev Med. 26:42014.
|
|
16
|
Li XD, Li XF, Ye HQ, Deng CL, Ye Q, Shan
C, Shang BD, Xu LL, Li SH, Cao SB, et al: Recovery of a chemically
synthesized Japanese encephalitis virus reveals two critical
adaptive mutations in NS2B and NS4A. J Gen Virol. 95:806–815. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen J, Zhao Y, Zhang C, Chen H, Feng J,
Chi X, Pan Y, Du J, Guo M, Cao H, et al: Persistent hepatitis C
virus infections and hepatopathological manifestations in
immune-competent humanized mice. Cell Res. 24:1050–1066. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shang B, Deng C, Ye H, Xu W, Yuan Z, Shi
PY and Zhang B: Development and characterization of a stable eGFP
enterovirus 71 for antiviral screening. Antiviral Res. 97:198–205.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qin B, Tu C, Zhang B, He T, Fu L and Xu W:
A modified murine model based on hydrodynamic injection for the
analysis of chronic human hepatitis B virus infection. Mol Med Rep.
8:1677–1682. 2013.PubMed/NCBI
|
|
20
|
Qin B, Budeus B, Cao L, Wu C, Wang Y,
Zhang X, Rayner S, Hoffmann D, Lu M and Chen X: The amino acid
substitutions rtP177G and rtF249A in the reverse transcriptase
domain of hepatitis B virus polymerase reduce the susceptibility to
tenofovir. Antiviral Res. 97:93–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen IC, Wang SM, Yu CK and Liu CC:
Subneutralizing antibodies to enterovirus 71 induce
antibody-dependent enhancement of infection in newborn mice. Med
Microbiol Immunol. 202:259–265. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li P, Yue YY, Song NN, Li ZH and Meng H:
Study on BALB/c mice with EV71 infection by diverse inoculation
routes. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi.
27:14–17. 2013.(In Chinese). PubMed/NCBI
|
|
23
|
Han JF, Yu N, Pan YX, He SJ, Xu LJ, Cao
RY, Li YX, Zhu SY, Zhang Y and Qin ED: Phenotypic and genomic
characterization of human coxsackievirus A16 strains with distinct
virulence in mice. Virus Res. 179:212–219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Teng S, Wei Y, Zhao SY, Lin XY, Shao QM
and Wang J: Intestinal detoxification time of hand-foot-and-mouth
disease in children with EV71 infection and the related factors.
World J Pediatr. 11:380–385. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Klein MH: EV71 vaccines: A first step
towards multivalent hand, foot and mouth disease vaccines. Expert
Rev Vaccines. 14:337–340. 2015. View Article : Google Scholar : PubMed/NCBI
|
